Rosalind Segal, MD, PhD
Rosalind Segal is a professor of neurobiology at Harvard Medical School, Ed Benz Chair of Cancer Biology at Dana-Farber Cancer Institute, and director of Harvard’s PhD program in neuroscience. Her research is at the intersection of developmental neurobiology and cancer biology and focuses on the mechanisms whereby the microenvironment regulates proliferation and survival pathway. Segal’s studies focus on the role of RNA Transport and local translation in promoting axonal survival and prevent axon degradation. She is also chair of SfN’s Neuroscience Training Committee. Segal earned her PhD from Rockefeller University and MD from Cornell University Medical College. She completed a residency in the Harvard neurology program and a postdoctoral fellowship at Massachusetts Institute of Technology.
Kenneth Maynard, PhD
Kenneth Maynard is a global program leader at Takeda Pharmaceuticals. His expertise in neuroscience focuses on cerebrovascular pathophysiology, specifically stroke. Maynard led a laboratory of medical students and neurosurgeons researching cerebral ischemia and stroke at Harvard Medical School, has worked as an assistant professor of neurosurgery, and was an assistant neuroscientist in the neurological service at Massachusetts General Hospital. Maynard is the former chair of SfN’s Professional Development Committee and a former member of SfN’s Finance Committee.
Letitia A. Weigand, PhD
Letitia A. Wigand is a program manager in the National Institute of Neurological Disorders and Stroke (NINDS) Office of Training, Career Development, and Workforce Diversity. She earned her PhD in physiology from the Johns Hopkins University Bloomberg School of Public Health and received postdoctoral training at the George Washington University in the Department of Pharmacology before joining NINDS in 2013. Her research interests have ranged from pulmonary physiology and pharmacology to neuroimmune interactions in the lungs to CNS control of heart rate.